Pere Millat-Martínez

935 total citations · 1 hit paper
11 papers, 283 citations indexed

About

Pere Millat-Martínez is a scholar working on Infectious Diseases, Epidemiology and Public Health, Environmental and Occupational Health. According to data from OpenAlex, Pere Millat-Martínez has authored 11 papers receiving a total of 283 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Infectious Diseases, 4 papers in Epidemiology and 3 papers in Public Health, Environmental and Occupational Health. Recurrent topics in Pere Millat-Martínez's work include COVID-19 Clinical Research Studies (3 papers), Malaria Research and Control (3 papers) and SARS-CoV-2 and COVID-19 Research (2 papers). Pere Millat-Martínez is often cited by papers focused on COVID-19 Clinical Research Studies (3 papers), Malaria Research and Control (3 papers) and SARS-CoV-2 and COVID-19 Research (2 papers). Pere Millat-Martínez collaborates with scholars based in Spain, Mozambique and Papua New Guinea. Pere Millat-Martínez's co-authors include Quique Bassat, Bàrbara Baró, Michael Marks, Marc Corbacho‐Monné, Núria Prat, Andrea Alemany, Aurelio Tobı́as, Ester Ballana, Cristian Tebé and Dan Ouchi and has published in prestigious journals such as PLoS ONE, Clinical Infectious Diseases and Antimicrobial Agents and Chemotherapy.

In The Last Decade

Pere Millat-Martínez

8 papers receiving 281 citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Transmission of COVID-19 in 282 clusters in Catalonia, Spain: a cohort study

2021 195 citations Michael Marks, Pere Millat-Martínez et al. The Lancet Infectious Diseases profile →

Peers

Countries citing papers authored by Pere Millat-Martínez

Since Specialization

Citations

This map shows the geographic impact of Pere Millat-Martínez's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Pere Millat-Martínez with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Pere Millat-Martínez more than expected).

Fields of papers citing papers by Pere Millat-Martínez

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Pere Millat-Martínez. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Pere Millat-Martínez. The network helps show where Pere Millat-Martínez may publish in the future.

Co-authorship network of co-authors of Pere Millat-Martínez

This figure shows the co-authorship network connecting the top 25 collaborators of Pere Millat-Martínez. A scholar is included among the top collaborators of Pere Millat-Martínez based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Pere Millat-Martínez. Pere Millat-Martínez is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

11 of 11 papers shown

#	Work	Indexed citations
1	Patient and donor antibody profiles in early COVID-19 convalescent plasma therapy in the COnV-ert trial 2025 ·Frontiers in Immunology ·Andrea Alemany, (unknown), Edwards Pradenas, Ruth Aguilar, Marta Vidal, Alfons Jiménez, Pere Millat-Martínez, Marc Corbacho‐Monné, Clara Suñer, Quique Bassat, Bàrbara Baró, Gemma Moncunill, (unknown), (unknown), Julià Blanco, Carlota Dobaño	0
2	Exploring reported causes of vaccine hesitancy among European adolescents and parents: results of a citizen science project 2025 ·BMC Public Health ·Pere Millat-Martínez, (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), Montse Esquerda, Alexandre Perera-Lluna, Begonya Nafría, Quique Bassat	4
3	Prognostic performance of early immune and endothelial activation markers in mild-to-moderate COVID-19 outpatients: a nested case-control study 2024 ·Frontiers in Immunology ·Andrea Alemany, (unknown), Pere Millat-Martínez, Dan Ouchi, Marc Corbacho‐Monné, Cristian Morales‐Indiano, (unknown), Ignacio Blanco, (unknown), Ruth Aguilar, Carlota Dobaño, Quique Bassat, Gemma Moncunill, Bàrbara Baró, (unknown)	0
4	Impact of COVID-19 Lockdown on the Nasopharyngeal Microbiota of Children and Adults Self-Confined at Home 2022 ·Viruses ·Muntsa Rocafort, Desirée Henares, Pedro Brotons, Cristian Launes, Mariona Fernández de Sevilla, Victòria Fumadó, Irene Barrabeig, (unknown), Alba Redin, Julia Ponomarenko, Maria Melé, Pere Millat-Martínez, Joana Claverol, (unknown), Álex Mira, Juan José García‐García, Quique Bassat, Iolanda Jordán, Carmen Muñoz‐Almagro	13
5	Piperaquine Pharmacokinetic and Pharmacodynamic Profiles in Healthy Volunteers of Papua New Guinea after Administration of Three-Monthly Doses of Dihydroartemisinin–Piperaquine 2022 ·Antimicrobial Agents and Chemotherapy ·Pere Millat-Martínez, Sam Salman, Brioni R. Moore, Bàrbara Baró, Madhu Page‐Sharp, Kevin T. Batty, Leanne J. Robinson, William Pomat, Harin Karunajeewa, Moses Laman, Laurens Manning, (unknown), Quique Bassat	0
6	How Did the COVID-19 Lockdown Affect Children and Adolescent's Well-Being: Spanish Parents, Children, and Adolescents Respond 2021 ·Frontiers in Public Health ·Sara Ajanovic, (unknown), Bàrbara Baró, (unknown), Rosauro Varo, Pere Millat-Martínez, (unknown), Jordi Fonollosa, Alexandre Perera-Lluna, Iolanda Jordán, Carmen Muñoz‐Almagro, Elisenda Bonet-Carné, (unknown), Esther Via, Begonya Nafría, Juan José García‐García, Quique Bassat	9
7	Transmission of COVID-19 in 282 clusters in Catalonia, Spain: a cohort study breakdown → 2021 ·The Lancet Infectious Diseases ·Michael Marks, Pere Millat-Martínez, Dan Ouchi, Chrissy h. Roberts, Andrea Alemany, Marc Corbacho‐Monné, María Ubals, Aurelio Tobı́as, Cristian Tebé, Ester Ballana, Quique Bassat, Bàrbara Baró, Martí Vall-Mayans, Camila González-Beiras, Núria Prat, Jordi Ara, Bonaventura Clotet, (unknown)	195
8	Coverage, determinants of use and repurposing of long-lasting insecticidal nets two years after a mass distribution in Lihir Islands, Papua New Guinea: a cross-sectional study 2021 ·Malaria Journal ·Pere Millat-Martínez, (unknown), (unknown), (unknown), Sergi Sanz, (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), Stephan Karl, Moses Laman, William Pomat, (unknown), Bàrbara Baró, Quique Bassat	6
9	Pharmacokinetic and safety study of co-administration of albendazole, diethylcarbamazine, Ivermectin and azithromycin for the integrated treatment of Neglected Tropical Diseases 2020 ·Clinical Infectious Diseases ·(unknown), (unknown), Pere Millat-Martínez, (unknown), (unknown), (unknown), (unknown), Yashpal S. Chhonker, Veenu Bala, Christopher L. King, Daryl J. Murry, (unknown), Michael Marks	9
10	Electrocardiographic Safety of Repeated Monthly Dihydroartemisinin-Piperaquine as a Candidate for Mass Drug Administration 2018 ·Antimicrobial Agents and Chemotherapy ·Pere Millat-Martínez, (unknown), Moses Laman, Leanne J. Robinson, Harin Karunajeewa, (unknown), (unknown), Sergi Sanz, Laurens Manning, Brioni R. Moore, Quique Bassat, (unknown)	5
11	Clinical Features, Etiology and Outcomes of Community-Acquired Pneumonia in Patients with Chronic Obstructive Pulmonary Disease 2014 ·PLoS ONE ·Joan Gómez‐Junyent, Carolina García‐Vidal, Diego Viasus, Pere Millat-Martínez, Antonella F. Simonetti, (unknown), Carmen Ardanuy, Jordi Dorca, Jordi Carratalà	42

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact